Related Experiment Video
Updated: Jun 8, 2026

TGF-β-mediated Endothelial to Mesenchymal Transition (EndMT) and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
Snail1 suppresses TGF-beta-induced apoptosis and is sufficient to trigger EMT in hepatocytes
D Lorena Franco1, Jèssica Mainez, Sonia Vega
1Instituto de Neurociencias (CSIC-UMH), 03550 San Juan de Alicante, Spain.
Abstract:
Although TGF-β suppresses early stages of tumour development, it later contributes to tumour progression when cells become resistant to its suppressive effects. In addition to circumventing TGF-β-induced growth arrest and apoptosis, malignant tumour cells become capable of undergoing epithelial-to-mesenchymal transition (EMT), favouring invasion and metastasis. Therefore, defining the mechanisms that allow cancer cells to escape from the suppressive effects of TGF-β is fundamental to understand tumour progression and to design specific therapies. Here, we have examined the role of Snail1 as a suppressor of TGF-β-induced apoptosis in murine non-transformed hepatocytes, rat and human hepatocarcinoma cell lines and transgenic mice. We show that Snail1 confers resistance to TGF-β-induced cell death and that it is sufficient to induce EMT in adult hepatocytes, cells otherwise refractory to this transition upon exposure to TGF-β. Furthermore, we show that Snail1 silencing prevents EMT and restores the cell death response induced by TGF-β. As Snail1 is a known target of TGF-β signalling, our data indicate that Snail1 might transduce the tumour-promoting effects of TGF-β, namely the EMT concomitant with the resistance to cell death.
Insights
Snail1 protein prevents cancer cell death and promotes epithelial-to-mesenchymal transition (EMT), aiding tumor spread. Targeting Snail1 may restore TGF-β
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Transforming growth factor-beta (TGF-β) initially suppresses tumors but later promotes progression in resistant cells.
- Cancer cells evade TGF-β-induced apoptosis and undergo epithelial-to-mesenchymal transition (EMT), enhancing invasion and metastasis.
Purpose of the Study:
- To investigate the role of Snail1 in mediating resistance to TGF-β-induced apoptosis and promoting EMT.
- To define mechanisms by which cancer cells escape TGF-β's suppressive effects for therapeutic development.
Main Methods:
- Examined Snail1's function in murine hepatocytes, rat and human hepatocarcinoma cell lines, and transgenic mice.
- Utilized Snail1 silencing to assess its impact on TGF-β response and EMT induction.
Main Results:
- Snail1 confers resistance to TGF-β-induced cell death in cancer cells.
- Snail1 is sufficient to induce EMT in hepatocytes, which are typically resistant to this transition.
- Snail1 silencing reversed EMT and restored TGF-β-induced apoptosis.
Conclusions:
- Snail1 acts as a key mediator of TGF-β's tumor-promoting effects, including EMT and apoptosis resistance.
- Targeting Snail1 could be a therapeutic strategy to counteract TGF-β-driven tumor progression.
Related Concept Videos
TGF - β Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The Extrinsic Apoptotic Pathway

